EligibleTrials

SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease

Recruiting · NCT05765110 · Interventional (participants receive a specific treatment) · Lead sponsor: Insel Gruppe AG, University Hospital Bern

View the official record on ClinicalTrials.gov →
Parkinson's disease

Interventions studied

DBS OFF stateDBS ON stateDopaminergic OFF drug stateDopaminergic ON drug state

What this trial is about

With this study, the investigators want to investigate whether computerized speech analysis can be used to reliably and objectively detect motor, emotional, and cognitive fluctuations in Parkinson's disease patients.

Who can take part

Age range
30 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.